Literature DB >> 15165747

Nicotinic acetylcholine receptors and the regulation of neuronal signalling.

Federico Dajas-Bailador1, Susan Wonnacott.   

Abstract

Neuronal nicotinic acetylcholine (nACh) receptors in the brain are more commonly associated with modulatory events than mediation of synaptic transmission. nACh receptors have a high permeability for Ca(2+), and Ca(2+) signals are pivotal in shaping nACh receptor-mediated neuromodulatory effects. In this review, we consider the mechanisms through which nACh receptors convert rapid ionic signals into sustained, wide-ranging phenomena. The complex Ca(2+) responses that are generated after activation of nACh receptors can transmit information beyond the initial domain and facilitate the interface with many intracellular processes. These mechanisms underlie the diverse repertoire of neuronal activities of nicotine in the brain, from the enhancement of learning and memory, to addiction and neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165747     DOI: 10.1016/j.tips.2004.04.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  176 in total

1.  Direct administration of ifenprodil and citalopram into the nucleus accumbens inhibits cue-induced nicotine seeking and associated glutamatergic plasticity.

Authors:  Jonna M Leyrer-Jackson; Jose A Piña; Joseph McCallum; M Foster Olive; Cassandra D Gipson
Journal:  Brain Struct Funct       Date:  2020-06-26       Impact factor: 3.270

2.  Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder epithelium of the rat.

Authors:  Jonathan M Beckel; Lori A Birder
Journal:  J Physiol       Date:  2012-01-16       Impact factor: 5.182

3.  Nicotinic neuromodulation in auditory cortex requires MAPK activation in thalamocortical and intracortical circuits.

Authors:  Irakli Intskirveli; Raju Metherate
Journal:  J Neurophysiol       Date:  2012-02-22       Impact factor: 2.714

Review 4.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

5.  Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1.

Authors:  Flavio H Beraldo; Camila P Arantes; Tiago G Santos; Nicolle G T Queiroz; Kirk Young; R Jane Rylett; Regina P Markus; Marco A M Prado; Vilma R Martins
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 6.  Targeting nicotinic receptors for Parkinson's disease therapy.

Authors:  Maryka Quik; Tanuja Bordia; Luping Huang; Xiomara Perez
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

7.  Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors.

Authors:  Adrian F Lozada; Xulong Wang; Natalia V Gounko; Kerri A Massey; Jingjing Duan; Zhaoping Liu; Darwin K Berg
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

8.  Prenatal choline supplementation increases sensitivity to time by reducing non-scalar sources of variance in adult temporal processing.

Authors:  Ruey-Kuang Cheng; Warren H Meck
Journal:  Brain Res       Date:  2007-10-22       Impact factor: 3.252

9.  Genetics and smoking.

Authors:  Anu Loukola; Jenni Hällfors; Tellervo Korhonen; Jaakko Kaprio
Journal:  Curr Addict Rep       Date:  2014-03-01

10.  Expeditious synthesis, enantiomeric resolution, and enantiomer functional characterization of (4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4BP-TQS): an allosteric agonist-positive allosteric modulator of α7 nicotinic acetylcholine receptors.

Authors:  Ganesh A Thakur; Abhijit R Kulkarni; Jeffrey R Deschamps; Roger L Papke
Journal:  J Med Chem       Date:  2013-10-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.